Your search history is turned on.
Date: April 26, 2024 Jurisdictions: Alberta, British Columbia, Ontario
DEFA14A 2024 AGM Notice UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use o...
ngne-20240426 40 41 ...
Focusing on the Future of Life-Changing GENETIC MEDICINES 2023 Annual Report www.neurogene.com Rett syndrome is a rare, X-linked neurodevelopmental disorder that occurs almost exclusively in females, and leads to severe impairments, including in communication, ambulation, hand function, and breathing. There are no approved treatments available that address the ...
ngne-20240426 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Comm...
ngne-20240426 535 W. 24th Street, 5th Floor, New York, NY 10011 NOTICE OF 2024 ANNUAL MEETING OF STOCKHOLDERS To Be Held Friday, June 14, 2024, 11:00 a.m. (Eastern Time) Virtual Meeting Only No Physical Meeting Location To Our Stockholders: NOTICE IS HEREBY GIVEN that the 2024 Annual Meeting of Stockholders ("Annual Meeting") of Neurogene Inc., a Delaware corporation (the ...
Date: April 25, 2024 Jurisdictions: Alberta, British Columbia, Ontario
Neurogene Inc. - Current report filing - Primary - 2024-04-25.pdf ...
Date: April 23, 2024 Jurisdictions: Alberta, British Columbia, Ontario
ngne-20240422 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 22, 2024 Neurogene Inc. (Exact name of registrant as specified in its charter) Delaware 001-36327 98-0542593 (State or other jurisdictio...
Date: April 3, 2024 Jurisdictions: Alberta, British Columbia, Ontario
ngne-20240401 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 1, 2024 Neurogene Inc. (Exact name of registrant as specified in its charter) Delaware 001-36327 98-0542593 (State or other jurisd...
Date: March 28, 2024 Jurisdictions: Alberta, British Columbia, Ontario
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 18, 2024 Neurogene Inc. (Exact name of registrant as specified in its charter) Delaware 001-36327 98-0542593 (State or other jurisdiction of incorpor...
Exhibit 31.2 CERTIFICATIONS I, Christine Mikail, certify that: 1. I have reviewed this Annual Report on Form 10-K of Neurogene Inc: 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not mislea...